PEDIALYTE FREEZER POPS OTC
Generic Name and Formulations:
Dextrose 1.6g, sodium 2.8mEq, potassium 1.25mEq, chloride 2.2mEq, Calories 6.25; per 62mL pop; grape, cherry, orange, or raspberry flavored; contains acesulfame.
Indications for PEDIALYTE FREEZER POPS:
Oral fluid and electrolyte replacement in mild to moderate diarrhea and vomiting.
Give frozen pop or unfrozen as a drink, with other fluid and electrolyte supplements. <1yr: not recommended. ≥1yr: give as desired by patient.
As sole therapy in severe continuing diarrhea. Intractable vomiting. Adynamic ileus. Intestinal obstruction or perforated bowel. Anuria, oliguria, or impaired homeostatic mechanism.
Fluid & electrolyte replacement.
Liq (flavored)—1L; Liq (unflavored)—2oz, 1L; Singles (6.8oz)—16; Pwd (packets)—4, 8; Pops—16
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|